TENS for Scleroderma-related Gastroparesis

This study is looking at how well a device called Transcutaneous Electrical Nerve Stimulation (TENS) works to help with stomach problems (gastroparesis) in people with Scleroderma. Gastroparesis can cause symptoms like bloating and feeling full. You might be able to join if you have Scleroderma and experience moderate to severe bloating. The main goal is to see if people find the TENS device acceptable to use. The study plans to enroll 16 participants, but its current status is unclear.

Study design
This is an interventional study planning to enroll 16 participants. It is a pilot study to assess the acceptability of the TENS device.
What's involved
You would use the TENS device for 45 minutes, twice a day, for 4 weeks. You would also fill out daily diaries and biweekly questionnaires during treatment, and daily diaries and weekly questionnaires during a 4-week follow-up period.
Compensation
Not stated in the trial record.
Follow-up
You will be asked to complete daily diaries and weekly questionnaires during a 4-week post-treatment follow-up period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06646913

TENS in Scleroderma

Completed
NAAges 18+InterventionalTreatment
University of Michigan
~11 participants
Updated 2026-08-13 on ClinicalTrials.gov
What's tested:Transcutaneous Electrical Nerve Stimulation

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Acceptability of the TENS Device
Measured over 4 weeks
Scleroderma
Gastroparesis
Systemic Sclerosis (SSc)
1 sites across 1 states
Michigan1

This trial hasn't published a contact. View it on ClinicalTrials.gov

  • Acceptability of the TENS Device4 weeks

    Acceptability of the TENS device as demonstrated by: 1. Subjects who are able to complete the trial by reaching the end of the testing period with the device 2. Subjects who utilize the device for at least 80% of the proposed applications.